ESOPAug 7, 2026, 07:06 AM
Cartesian Therapeutics Grants 115,250 Stock Options to New Hires
AI Summary
Cartesian Therapeutics, Inc. announced the granting of inducement awards to four new employees. These awards consist of options to purchase an aggregate of 115,250 shares of the Company's common stock. The options have grant dates of August 3, 2026 and August 6, 2026, and will vest over a four-year period, with full vesting by August 2030. The grants were made under the Company's Amended and Restated 2018 Employment Inducement Incentive Award Plan and approved by the board of directors.
Key Highlights
- Granted inducement awards to four new employees.
- Awards consist of options to purchase 115,250 shares of common stock.
- Grant dates were August 3, 2026 and August 6, 2026.
- Options have an exercise price equal to closing trading price on grant dates.
- Options vest over a four-year period, fully vested by August 2030.
- 25% vests on first anniversary, remaining 75% in monthly installments.
- Options have a ten-year term.
- Granted under Company's Amended and Restated 2018 Employment Inducement Incentive Award Plan.
Price Impact
More from RNAC